These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31802398)

  • 1. Authors' Reply to Nicolas: "Why Were More than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".
    Concordet D; Gandia P; Montastruc JL; Bousquet-Mélou A; Lees P; Ferran AA; Toutain PL
    Clin Pharmacokinet; 2020 Feb; 59(2):277-279. PubMed ID: 31802398
    [No Abstract]   [Full Text] [Related]  

  • 2. Authors' Reply to Krebs-Brown et al. Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".
    Concordet D; Gandia P; Montastruc JL; Bousquet-Mélou A; Lees P; Ferran AA; Toutain PL
    Clin Pharmacokinet; 2020 Feb; 59(2):269-271. PubMed ID: 31802401
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".
    Krebs-Brown A; Munafo A; Gaikwad S; Urgatz B; Castello-Bridoux C
    Clin Pharmacokinet; 2020 Feb; 59(2):265-267. PubMed ID: 31802400
    [No Abstract]   [Full Text] [Related]  

  • 4. Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".
    Nicolas P
    Clin Pharmacokinet; 2020 Feb; 59(2):273-275. PubMed ID: 31802399
    [No Abstract]   [Full Text] [Related]  

  • 5. When Bioequivalence in Healthy Volunteers May not Translate to Bioequivalence in Patients: Differential Effects of Increased Gastric pH on the Pharmacokinetics of Levothyroxine Capsules and Tablets.
    Seng Yue C; Benvenga S; Scarsi C; Loprete L; Ducharme MP
    J Pharm Pharm Sci; 2015; 18(5):844-55. PubMed ID: 26670370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levothyroxine Bioequivalence Study and Its Narrow Therapeutic Index: Comparative Bioavailability Results Between Two Formulations Available in Latin America.
    Bertoncini CW; Palacios MJC; Fritz MC; Rodriguez MP; Acevedo C; Hunzicker GA; Dominguez MC; Arbeláez I
    Adv Ther; 2023 Apr; 40(4):1644-1654. PubMed ID: 36422808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
    Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
    Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence study of levothyroxine tablets compared to reference tablets and an oral solution.
    Koytchev R; Lauschner R
    Arzneimittelforschung; 2004; 54(10):680-4. PubMed ID: 15553108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New levothyroxine formulation meeting 95-105% specification over the whole shelf-life: results from two pharmacokinetic trials.
    Gottwald-Hostalek U; Uhl W; Wolna P; Kahaly GJ
    Curr Med Res Opin; 2017 Feb; 33(2):169-174. PubMed ID: 27718637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?
    Concordet D; Gandia P; Montastruc JL; Bousquet-Mélou A; Lees P; Ferran AA; Toutain PL
    Clin Pharmacokinet; 2020 Jan; 59(1):1-5. PubMed ID: 31432471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.
    Dong BJ; Hauck WW; Gambertoglio JG; Gee L; White JR; Bubp JL; Greenspan FS
    JAMA; 1997 Apr; 277(15):1205-13. PubMed ID: 9103344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bioequivalence study of levothyroxine tablets versus an oral levothyroxine solution in healthy volunteers.
    Yannovits N; Zintzaras E; Pouli A; Koukoulis G; Lyberi S; Savari E; Potamianos S; Triposkiadis F; Stefanidis I; Zartaloudis E; Benakis A
    Eur J Drug Metab Pharmacokinet; 2006; 31(2):73-8. PubMed ID: 16898074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new formulation of levothyroxine engineered to meet new specification standards.
    Lipp HP; Hostalek U
    Curr Med Res Opin; 2019 Jan; 35(1):147-150. PubMed ID: 30406687
    [No Abstract]   [Full Text] [Related]  

  • 14. Levothyroxine soft capsules demonstrate bioequivalent pharmacokinetic exposure with the European reference tablets in healthy volunteers under fasting conditions.
    Al-Numani D; Scarsi C; Ducharme MP
    Int J Clin Pharmacol Ther; 2016 Feb; 54(2):135-43. PubMed ID: 26754305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Bioavailability of a Novel Solution and a Tablet Formulation of Levothyroxine.
    Vandse S; Psarrakis Y; Washington K; Baron MA
    Clin Pharmacol Drug Dev; 2023 May; 12(5):502-508. PubMed ID: 36876643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual bioequivalence for achlorhydric subjects: The use of PBPK modelling to assess the formulation-dependent effect of achlorhydria.
    Doki K; Darwich AS; Patel N; Rostami-Hodjegan A
    Eur J Pharm Sci; 2017 Nov; 109():111-120. PubMed ID: 28774813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence of levothyroxine tablets administered to a target population in steady state.
    Cerutti R; Rivolta G; Cavalieri L; Di Giulio C; Grossi E; Vago T; Baldi G; Righini V; Marzo A
    Pharmacol Res; 1999 Mar; 39(3):193-201. PubMed ID: 10094844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation into the influence of experimental conditions on in vitro drug release from immediate-release tablets of levothyroxine sodium and its relation to oral bioavailability.
    Kocic I; Homsek I; Dacevic M; Parojcic J; Miljkovic B
    AAPS PharmSciTech; 2011 Sep; 12(3):938-48. PubMed ID: 21748540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levothyroxine sodium tablets: chemical equivalence and bioequivalence.
    Curry SH; Gums JG; Williams LL; Curry RW; Wolfson BB
    Drug Intell Clin Pharm; 1988; 22(7-8):589-91. PubMed ID: 3046889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of sex-by-formulation interaction in bioequivalence studies of efavirenz tablets.
    González-Rojano E; Abad-Santos F; Ochoa D; Román M; Marcotegui J; Álvarez C; Gordon J; García-Arieta A
    Br J Clin Pharmacol; 2018 Aug; 84(8):1729-1737. PubMed ID: 29633302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.